worldwide locations | contacts | sitemap

 

 

 

 

About Novartis

PrinttextDecrease text sizeIncrease text size

Stories

2012

2011

2010

Mark Fishman reflects on 10 years of NIBR
Mark Fishman started heading up research & development (R&D) at Novartis, as President of the Novartis Institutes for BioMedical Research (NIBR), 10 years ago.

 

Clinical sciences

Incorporating clinical medicine into its early stage "benchtop" drug discovery...

Read more about what we do

Disease areas

Understanding the underlying molecular basis of disease has enabled NIBR to turn scientific insights into medical breakthroughs.

Learn more

Discovery and Pre/ Clinical Sciences

Applying key expertise and technologies across diseases that share similar mechanisms...

Learn more about Discovery and Pre/ Clinical Sciences at NIBR

 

NIBR Locations

NIBR Research Locations

Helpful links

Alliance Proposals

Diversity & Inclusion

Novartis.com

Published Research

Follow us

Novartis FacebookNovartis YouTube

Subscribe to NIBR stories

NIBR on Flickr